gadolinium has been researched along with Renal Insufficiency in 129 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (3.88) | 18.2507 |
| 2000's | 75 (58.14) | 29.6817 |
| 2010's | 37 (28.68) | 24.3611 |
| 2020's | 12 (9.30) | 2.80 |
| Authors | Studies |
|---|---|
| Amalia, SN; Bhattarai, A; Kartamihardja, AAP; Koyama, H; Motegi, SI; Sekiguchi, A; Taketomi-Takahashi, A; Tsushima, Y | 1 |
| Coimbra, S; Reis Sousa, N; Rocha, S; Santos-Silva, A; Valente, MJ | 1 |
| Davies, J; Evans, P; Jones, P; Siebenhandl-Wolff, P; Tranquart, F | 1 |
| Dinh, H; Lountzis, NI; Phan, J; Purcell, SM | 1 |
| Li, K; Wang, J; Wu, D; Yue, W; Zha, M; Zhao, H | 1 |
| Leonberg-Yoo, AK; Rudnick, MR; Wahba, IM | 1 |
| Cheong, BYC; Muthupillai, R; Preventza, OA; Wilson, JM | 1 |
| Bonafè, R; Bussi, S; Coppo, A; Kirchin, MA; Maisano, F; Queliti, R; Tedoldi, F | 1 |
| Bo, R; Jia, B; Li, L; Li, Y; Lin, TY; Lindstrom, A; Louie, AY; Ma, Z; Qu, H; Ricci, M; Vapniarsky, N; Wu, H; Xiao, W; Xue, X; Yuan, Y; Zhang, D; Zhu, Z | 1 |
| Falkenberg, G; Osterode, W; Regele, H | 1 |
| Bruno, F; DeAguero, J; Do, C; Escobar, GP; Lee, DY; Tan, C; Wagner, B | 1 |
| Bocanegra, J; Corot, C; Factor, C; Fretellier, N; Idée, JM; Rasschaert, M; Robert, P; Seron, A | 1 |
| Burris, NS; Foster, ED; Hope, MD; Mahadevan, VS; Mukai, K; Ordovas, KG | 1 |
| Garcia, J; Liu, SZ; Louie, AY | 1 |
| Das, K; Pullicino, R | 1 |
| Archer, JRH; Dargan, PI; Layne, KA; Wood, DM | 1 |
| Deray, G; Janus, N; Launay-Vacher, V | 1 |
| Addobbati, R; Altissimo, M; Biasotto, M; Candido, R; Delfino, R; Pascolo, L; Šala, M; Salomè, M; Stebel, M; Tromba, G; van Elteren, JT; Vogel Mikuš, K; Zennaro, C | 1 |
| Leyba, K; Wagner, B | 1 |
| Chen, C; He, Q; Hu, X; Hyeon, T; Kim, D; Li, F; Liao, H; Ling, D; Liu, J; Liu, Y; Wang, N; Weng, Q; Xia, F; Yang, B; Zheng, J | 1 |
| Higashi, H; Ito, K; Kanki, A; Nishimura, H; Sato, T; Tamada, T; Tanimoto, D; Watanabe, S; Yamamoto, A | 1 |
| Gross, GE; Heitland, P; Jonas, L; Kühn-Velten, WN; Schäd, SG | 1 |
| Barnes, JL; Do, C; Tan, C; Wagner, B | 1 |
| Vogt, B | 1 |
| Bonnemain, B; Bruneval, P; Chevalier, T; Corot, C; Delaloge, F; Fabicki, JM; Factor, C; Fretellier, N; Idée, JM; Jestin-Mayer, G; Mayer, JF; Robic, C; Salhi, M; Schroeder, J; Siegmund, H | 1 |
| Parikh, MR; Perez, SD; Runge, TM; Sakaria, SS; Shaffer, KM; Subramanian, RM | 1 |
| He, A; Kwatra, SG; Loss, MJ; Zampella, JG | 1 |
| Kameo, S; Kartamihardja, AA; Koyama, H; Nakajima, T; Tsushima, Y | 1 |
| Hirose, Y; Ishii, Y; Johnson, K; Kabasawa, H; Motoyama, D; Nasu, H; Ohishi, N; Ozono, S; Sakahara, H; Sugiyama, M; Takehara, Y; Ushio, T; Wakayama, T; Wieben, O; Yang, W | 1 |
| Laranjeira, M; Miyazaki, T; Monteiro, FJ; Shirosaki, Y; Yoshimatsu Yasutomi, S | 1 |
| Bennett, LK; Garrett, AL | 1 |
| Brambilla, S; Graziani, G; Montanelli, A; Valaperta, S | 1 |
| Elenitsas, R; Introcaso, CE; James, WD; Xu, X | 1 |
| Altun, E; Fuller, ER; Leyendecker, JR; Martin, DR; Mitchell, DG; O'Malley, RB; Parsons, DJ; Semelka, RC; Wertman, R | 1 |
| Bhave, G; Chang, SS; Lewis, JB | 1 |
| DeLapaz, RL; Grossman, ME; Lee, HJ; MacGregor, JL; Magro, CM; Morris, M; Prince, MR; Silberzweig, J; Valeri, AM; Zhang, H | 1 |
| Algranati, S; García Mónaco, R; Greloni, G; Hidalgo Parra, I; Rosa Diez, G; Torre, A | 1 |
| Shellock, FG; Spinazzi, A | 1 |
| Colletti, PM | 1 |
| Vitti, RA | 1 |
| Frenzel, T; Hütter, J; Lengsfeld, P; Löwe, A; Pietsch, H; Sieber, MA; Steger-Hartmann, T | 1 |
| Francès, C; Lipsker, D; Senet, P | 1 |
| Contreras, G; Lenz, O; Ortega, LM | 1 |
| Gossner, J | 1 |
| Barkhausen, J; Daul, AE; Erbel, R; Hillen, U; Kribben, A; Witzke, O | 1 |
| Andreu Navarro, FJ; Fortuño Andrés, JR; Ibeas López, J; Orellana Fernández, R; Rodríguez Jornet, A | 1 |
| Bainotti, S; Formica, M; Nallino, MG; Rota, E | 1 |
| Bernheisel, CR; Schlaudecker, JD | 1 |
| Chung, M; Silberzweig, JI | 1 |
| Kucharczyk, W; Leiner, T | 1 |
| Isoda, H; Miki, Y; Togashi, K | 1 |
| Canavese, C; Fenoglio, R; Quaglia, M; Stratta, P | 1 |
| Anderson, CJ; Duncan, JR; Miner, JH; Sherman, CD; Wadas, TJ | 1 |
| Clément, O; Faye, N; Fournier, L; Frija, G; Siauve, N | 1 |
| Beurdeley, M; Dacher, JN; Dolores, M; Elbaz, F; Le Cloirec, J; Liard, A; Roset, JB; Vivier, PH | 1 |
| Abraham, JL; Barker-Griffith, A; Goldberg, J | 1 |
| Djamali, A; Haemel, AK; Sadowski, EA; Shafer, MM | 1 |
| Elmholdt, TR; Jensen, JD; Jørgensen, B; Olesen, AB; Pedersen, M; Ramsing, M; Søndergaard, K | 1 |
| Bouzian, N; Bruneval, P; Corot, C; Daubiné, F; Dencausse, A; Factor, C; Fretellier, N; Guerret, S; Idée, J; Jestin, G; Laprévote, O; Mandet, C; Massicot, F; Port, M; Poveda, N | 1 |
| Juneman, E; Movahed, MR; Saleh, L | 1 |
| Almén, T; Aspelin, P; Bellin, MF; Clement, O; Heinz-Peer, G; Morcos, SK; Reimer, P; Stacul, F; Thomsen, HS; van der Molen, AJ; Webb, JA | 1 |
| Aslam, MN; Bhagavathula, N; Bleavins, K; Dame, MK; Meshinchi, S; Naik, M; Perone, P; Rehman, M; Varani, J | 1 |
| Alhadad, A; Alhadad, H; Leander, P; Sterner, G; Svensson, Å | 1 |
| Kucharczyk, W; Leiner, T; Prince, MR; Roditi, GH; Zhang, HL; Zou, Z | 1 |
| Aoki, S; Cho, N; Hori, M; Hoshito, H; Kuwatsuru, R; Kyogoku, S; Nakanishi, A; Ozaki, Y; Sasai, K; Sato, S; Shimoji, K; Suzuki, M | 1 |
| Kitajima, K; Maeda, T; Sugimura, K; Ueno, Y; Watanabe, S | 1 |
| Ishii, T | 1 |
| Mori, H | 1 |
| Bouzian, N; Bruneval, P; Corot, C; Daubiné, F; Factor, C; Fretellier, N; Hollenbeck, C; Idée, JM; Jestin, G; Laprévote, O; Mandet, C; Massicot, F; Parmentier, N; Port, M | 1 |
| Bonneville, F; Bonneville, JF; Cattin, F; Huart, JY; Miralbes, S; Quantin, N; Robert, A | 1 |
| Elhajj, L; Mourani, C; Nassar, J; Noun, C; Slaba, S | 1 |
| Hamasaki, O; Katoh, Y; Nakahara, T; Sakoda, K; Wakasa, T | 1 |
| Azar, R; Badaoui, G; Bassil, R; Jebara, VA; Sarkis, A; Sleilaty, G | 1 |
| Blumenfeld, J; Bush, HL; Erel, HE; Kent, KC; Lent, RW; Prince, MR; Wang, Y | 1 |
| Thomsen, HS | 1 |
| Bader, BD; Berger, ED; Duda, S; Erley, CM; Risler, T; Tepe, G; Tuncel, N; Winkler, S | 1 |
| Lindell, EP; Manno, EM; Maramattom, BV; Wijdicks, EF | 1 |
| Ayers, RA; Chandler, J; Cowper, SE; High, WA; Zito, G | 1 |
| Hellman, RN | 1 |
| Chewning, RH; Murphy, KJ | 1 |
| Galaria, N; Gust, A; Hanjani, NM; Poggioli, G; Pryor, JG; Robison, J; Samie, F; Scott, GA | 1 |
| Bongartz, G | 1 |
| Grobner, T; Prischl, FC | 1 |
| Hugo, C | 1 |
| Brossmann, J; Herrlinger, JD; Jürgensen, T | 1 |
| Heymann, WR | 1 |
| Peak, AS; Sheller, A | 1 |
| Perazella, MA | 1 |
| Abul-Ezz, S; Bornhorst, JA; Horn, TD; Pellowski, D; Shah, SV; Swaminathan, S; Viswamitra, S | 1 |
| Collidge, TA; Jardine, AG; Mark, PB; Morris, ST; Roditi, GH; Simpson, K; Thomson, PC; Traynor, JP | 1 |
| Simpson, EL; Wahba, IM; White, K | 1 |
| Shah, SV; Swaminathan, S | 1 |
| Broome, DR; Kanal, E; Martin, DR; Thomsen, HS | 1 |
| Budisavljevic, MN; Maize, JC; Othersen, JB; Woolson, RF | 1 |
| Greenberg, CS; Parsons, AC; Sane, DC; Sangüeza, OP; Sheehan, DJ; Yosipovitch, G | 1 |
| Cheng, S; Saab, G | 1 |
| Baramidze, G; Lauenstein, TC; Martin, DR; Morreira, R; Salman, K; Singh-Parker, S; Tata, S; Tudorascu, D | 1 |
| Ersoy, H; Rybicki, FJ | 1 |
| Barkhausen, J; Daul, A; Hillen, U; Kribben, A; Witzke, O | 1 |
| Clément, O | 1 |
| Martin, DR | 1 |
| Cowper, SE | 2 |
| Weinreb, JC | 2 |
| Kuo, PH | 1 |
| Bucala, R | 1 |
| Girardi, M | 1 |
| Shenoy, C | 1 |
| Hiremagalur, B; Kurtkoti, J; Snow, T | 1 |
| Garovic, VD; Kalnicka, D; Kane, GC; Lee, CU; Rosenthal, DW; Stanson, AW; Textor, SC | 1 |
| Bos, JD; Keur, I; Scheepstra, CG; van der Meij, N; van Lienden, KP | 1 |
| Cohan, RH; Ellis, JH; Francis, IR; Hussain, HK; Mukherji, SK; Shabana, WM; Su, LD; Swartz, RD | 1 |
| Scheinfeld, N | 1 |
| Boyden, TF; Gurm, HS | 1 |
| Abraham, JL; Thakral, C | 1 |
| Marckmann, P; Nielsen, AH; Sloth, JJ | 1 |
| Aime, S; Canavese, C; Stratta, P | 1 |
| Lenkinski, RE; Rofsky, NM; Sherry, AD | 1 |
| Endo, K; Takahashi-Taketomi, A; Tsushima, Y | 1 |
| Arsenault, TM; Ehman, RL; Goodman, JA; King, BF; Marsh, JW; Weaver, AL; Wood, CP | 1 |
| Heuck, A; Reiser, M | 1 |
| Baker, JF; Barr, R; Barr, W; Barron, B; Free, R; Gazelle, GS; Lambrecht, LJ; Maravilla, KR; Pierro, JA; Seltzer, S; Stevens, GR; Swan, SK; Tucker, RM | 1 |
| Bensel, K; Davies, BE; LaFrance, ND; Lambrecht, LJ; McCloud, S; Parker, JR; Swan, SK; Townsend, R | 1 |
| Bazari, H; Geller, SC; Kaufman, JA; Waltman, AC | 1 |
| Casey, SO; Madison, MT; Nussbaum, ES; Sebring, LA | 1 |
| Bensel, K; Cohen, DL; Davies, BE; Katholi, R; Lambrecht, L; Parker, J; Swan, SK; Townsend, RR | 1 |
| Storck, M; Wagner, HJ | 1 |
42 review(s) available for gadolinium and Renal Insufficiency
| Article | Year |
|---|---|
Gadolinium: pharmacokinetics and toxicity in humans and laboratory animals following contrast agent administration.
Topics: Animals; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency | 2022 |
Gadolinium-Based Contrast Agents: Updates and Answers to Typical Questions Regarding Gadolinium Use.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency | 2022 |
Biological effects of MRI contrast agents: gadolinium retention, potential mechanisms and a role for phosphorus.
Topics: Animals; Brain; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Models, Biological; Molecular Imaging; Nephrogenic Fibrosing Dermopathy; Phosphorus; Renal Insufficiency | 2017 |
Gadolinium deposition and the potential for toxicological sequelae - A literature review of issues surrounding gadolinium-based contrast agents.
Topics: Animals; Bone and Bones; Brain; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Renal Insufficiency; Tissue Distribution | 2018 |
Gadolinium-based contrast agents: why nephrologists need to be concerned.
Topics: Contrast Media; Gadolinium; Glomerular Filtration Rate; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Nephrology; Renal Insufficiency; Risk Factors | 2019 |
Nephrogenic systemic fibrosis: is gadolinium the missing piece to the puzzle?
Topics: Acidosis; Contrast Media; Fibrosis; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Renal Dialysis; Renal Insufficiency; Risk Factors; Skin; Skin Diseases | 2008 |
Gadolinium and lanthanum: a iatrogenic transmetallation?
Topics: Gadolinium; Humans; Iatrogenic Disease; Kidney Failure, Chronic; Lanthanum; Renal Insufficiency; Scleroderma, Systemic; Syndrome | 2008 |
Association of gadolinium based magnetic resonance imaging contrast agents and nephrogenic systemic fibrosis.
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Renal Insufficiency; Skin Diseases | 2008 |
MRI safety update 2008: part 1, MRI contrast agents and nephrogenic systemic fibrosis.
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Renal Insufficiency; Skin Diseases | 2008 |
[Nephrogenic fibrosing dermopathy or nephrogenic systemic fibrosis? What do we know and what do we have to learn?].
Topics: Chelating Agents; Contraindications; Contrast Media; Fibroblasts; Gadolinium; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Kidney Function Tests; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Pentoxifylline; Photopheresis; Physical Therapy Modalities; Plasmapheresis; Practice Guidelines as Topic; Renal Dialysis; Renal Insufficiency; Risk Factors | 2009 |
Nephrogenic systemic fibrosis: pathogenesis, diagnosis, and therapy.
Topics: Contrast Media; Gadolinium; Germany; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency; Risk Factors | 2009 |
[Gadolinium-induced systemic fibrosis in advanced kidney failure].
Topics: Contrast Media; Disease Progression; Fibrosis; Gadolinium; Humans; Male; Middle Aged; Radiography; Renal Insufficiency | 2009 |
Removal of gadolinium by dialysis: review of different strategies and techniques.
Topics: Contrast Media; Dialysis; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency | 2009 |
NSF prevention in clinical practice: summary of recommendations and guidelines in the United States, Canada, and Europe.
Topics: Canada; Contrast Media; Dose-Response Relationship, Drug; Europe; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Practice Guidelines as Topic; Renal Insufficiency; United States | 2009 |
[Kidney and iodinated and gadolinium-based contrast agents].
Topics: Aged; Contrast Media; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fluid Therapy; Gadolinium; Glomerular Filtration Rate; Humans; Injections, Intra-Arterial; Injections, Intravenous; Iodine; Kidney Function Tests; Magnetic Resonance Angiography; Nephrogenic Fibrosing Dermopathy; Pulmonary Embolism; Renal Insufficiency; Risk Assessment | 2011 |
[Imaging evaluation of renal function: principles and limitations].
Topics: Contrast Media; Diagnosis, Differential; Diagnostic Imaging; Diffusion Magnetic Resonance Imaging; Electron Spin Resonance Spectroscopy; Gadolinium; Glomerular Filtration Rate; Humans; Kidney Calculi; Kidney Function Tests; Magnetic Resonance Imaging; Oxygen; Radionuclide Imaging; Renal Insufficiency; Sensitivity and Specificity; Technetium Tc 99m Dimercaptosuccinic Acid; Technetium Tc 99m Mertiatide; Tomography, X-Ray Computed; Ultrasonography; Ureteral Obstruction | 2011 |
Update on nephrogenic systemic fibrosis: are we making progress?
Topics: Contrast Media; Evidence-Based Medicine; Gadolinium; Humans; Inflammation; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency; Risk Factors | 2011 |
The use of gadolinium in patients with contrast allergy or renal failure requiring coronary angiography, coronary intervention, or vascular procedure.
Topics: Contrast Media; Coronary Angiography; Evidence-Based Medicine; Gadolinium; Humans; Hypersensitivity; Iodine Compounds; Radiography, Interventional; Renal Insufficiency; Risk Assessment; Risk Factors | 2011 |
Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines.
Topics: Contrast Media; Coronary Angiography; Europe; Female; Fluid Therapy; Gadolinium; Glomerular Filtration Rate; Heart Failure; Humans; Injections, Intra-Arterial; Injections, Intravenous; Iodine; Male; Practice Guidelines as Topic; Renal Insufficiency; Risk Factors; Sodium Bicarbonate; Sodium Chloride | 2011 |
Nephrogenic systemic fibrosis: review of 370 biopsy-confirmed cases.
Topics: Biopsy; Contrast Media; Dose-Response Relationship, Drug; Gadolinium; Glomerular Filtration Rate; Humans; Kidney; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Patient Selection; Renal Dialysis; Renal Insufficiency; Risk Assessment; Risk Factors; Skin | 2011 |
Recent topics related to nephrogenic systemic fibrosis associated with gadolinium-based contrast agents.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency; Risk Factors | 2012 |
Gadolinium-based contrast media and the development of nephrogenic systemic fibrosis in patients with renal insufficiency.
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Image Enhancement; Kidney; Magnetic Resonance Imaging; Renal Insufficiency; Scleroderma, Systemic | 2007 |
Imaging in the time of NFD/NSF: do we have to change our routines concerning renal insufficiency?
Topics: Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Practice Patterns, Physicians'; Renal Insufficiency; Risk Assessment; Risk Factors; Skin Diseases | 2007 |
Gadolinium and nephrogenic systemic fibrosis.
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Kidney; Magnetic Resonance Imaging; Renal Insufficiency; Scleroderma, Systemic; Skin | 2007 |
[Nephrology 2007].
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Gadolinium; Germany; Glomerular Filtration Rate; Hemoglobins; Humans; Kidney Diseases, Cystic; Kidney Transplantation; Mineralocorticoid Receptor Antagonists; Prognosis; Renal Dialysis; Renal Insufficiency; Risk Factors; Severity of Illness Index | 2007 |
Risk factors for developing gadolinium-induced nephrogenic systemic fibrosis.
Topics: Contrast Media; Drug Interactions; Fibrosis; Gadolinium; Humans; Renal Insufficiency; Risk Factors | 2007 |
Gadolinium is not the only trigger for nephrogenic systemic fibrosis: insights from two cases and review of the recent literature.
Topics: Adult; Female; Gadolinium; Glomerular Filtration Rate; Heart Transplantation; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lupus Erythematosus, Systemic; Postoperative Complications; Renal Insufficiency | 2007 |
New insights into nephrogenic systemic fibrosis.
Topics: Blood Vessels; Erythropoietin; Fibrosis; Gadolinium; Humans; Inflammation; Iron; Renal Insufficiency | 2007 |
Nephrogenic systemic fibrosis: a nephrologist's perspective.
Topics: Contrast Media; Decision Making; Fibrosis; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Renal Insufficiency; Risk Factors | 2007 |
Nephrogenic systemic fibrosis: center case review.
Topics: Adolescent; Adult; Aged; Cohort Studies; Comorbidity; Contrast Media; Female; Fibrosis; Gadolinium; Humans; Incidence; Magnetic Resonance Imaging; Male; Middle Aged; Renal Insufficiency; Risk Assessment; Risk Factors; Skin Diseases | 2007 |
Biochemical safety profiles of gadolinium-based extracellular contrast agents and nephrogenic systemic fibrosis.
Topics: Contrast Media; Dose-Response Relationship, Drug; Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Renal Insufficiency; Skin Diseases | 2007 |
[Nephrogenic systemic fibrosis--a new interdisciplinary challenge].
Topics: Biopsy; Contraindications; Contrast Media; Diagnosis, Differential; Fibrosis; Gadolinium; Gadolinium DTPA; Germany; Glucocorticoids; Humans; Kidney Transplantation; Magnetic Resonance Imaging; Photopheresis; Plasmapheresis; Prednisone; Registries; Renal Insufficiency; Risk Factors; Skin; Skin Diseases | 2007 |
Nephrogenic systemic fibrosis.
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Renal Insufficiency; Retrospective Studies; Risk Factors; Skin | 2008 |
Nephrogenic systemic fibrosis: a review and exploration of the role of gadolinium.
Topics: Comorbidity; Contrast Media; Diagnosis, Differential; Endothelin-1; Fibrosis; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Renal Insufficiency; Skin | 2007 |
Nephrogenic systemic fibrosis: an overview.
Topics: Acidosis; Animals; Contrast Media; Fibrosis; Gadolinium; Humans; Kidney; Magnetic Resonance Imaging; Renal Insufficiency; Skin; Skin Diseases | 2008 |
Gadolinium-containing MRI contrast agents: important variations on a theme for NSF.
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Renal Insufficiency; Skin; Skin Diseases; Thermodynamics | 2008 |
Circulating fibrocytes: cellular basis for NSF.
Topics: Animals; Cell Differentiation; Cell Proliferation; Connective Tissue; Contrast Media; Fibroblasts; Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Renal Insufficiency; Skin; Skin Diseases | 2008 |
Nephrogenic systemic fibrosis: a dermatologist's perspective.
Topics: Contrast Media; Diagnosis, Differential; Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Renal Insufficiency; Skin; Skin Diseases | 2008 |
Gadolinium and nephrogenic systemic fibrosis: association or causation.
Topics: Contrast Media; Epidemiologic Methods; Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Patient Selection; Practice Guidelines as Topic; Renal Insufficiency; Risk Assessment; Risk Factors; Severity of Illness Index; Skin Diseases | 2008 |
Does gadolinium-based angiography protect against contrast-induced nephropathy?: a systematic review of the literature.
Topics: Angiography; Contrast Media; Dose-Response Relationship, Drug; Evidence-Based Medicine; Gadolinium; Humans; Incidence; Iodine Compounds; Patient Selection; Renal Insufficiency; Risk Assessment; Risk Factors | 2008 |
Tissue distribution and kinetics of gadolinium and nephrogenic systemic fibrosis.
Topics: Animals; Clinical Trials as Topic; Contrast Media; Fibrosis; Gadolinium; Humans; Kidney; Magnetic Resonance Imaging; Renal Insufficiency; Skin; Skin Diseases; Tissue Distribution | 2008 |
Gadolinium-enhanced magnetic resonance imaging, renal failure and nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy.
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Kidney Diseases; Magnetic Resonance Imaging; Renal Dialysis; Renal Insufficiency; Risk; Skin Diseases | 2008 |
4 trial(s) available for gadolinium and Renal Insufficiency
| Article | Year |
|---|---|
Gadolinium-based contrast media compared with iodinated media for digital subtraction angiography in azotaemic patients.
Topics: Aged; Angiography, Digital Subtraction; Aortic Aneurysm; Contrast Media; Double-Blind Method; Female; Gadolinium; Glomerular Filtration Rate; Humans; Iohexol; Male; Middle Aged; Organometallic Compounds; Pilot Projects; Renal Artery Obstruction; Renal Insufficiency; Severity of Illness Index; Uremia; Vascular Diseases | 2004 |
Pharmacokinetics, safety, and tolerability of gadoversetamide injection (OptiMARK) in subjects with central nervous system or liver pathology and varying degrees of renal function.
Topics: Adult; Central Nervous System; Central Nervous System Diseases; Contrast Media; Double-Blind Method; Female; Gadolinium; Humans; Injections, Intravenous; Liver; Liver Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Renal Insufficiency; Safety | 1999 |
Safety and pharmacokinetic profile of gadobenate dimeglumine in subjects with renal impairment.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Double-Blind Method; Female; Gadolinium; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Renal Insufficiency; Safety; Spectrophotometry, Atomic | 1999 |
Safety of intravenous gadolinium (Gd-BOPTA) infusion in patients with renal insufficiency.
Topics: Contrast Media; Double-Blind Method; Gadolinium; Humans; Infusions, Intravenous; Meglumine; Organometallic Compounds; Renal Insufficiency | 2000 |
83 other study(ies) available for gadolinium and Renal Insufficiency
| Article | Year |
|---|---|
Neutrophil elastase in the development of nephrogenic systemic fibrosis (NSF)-like skin lesion in renal failure mouse model.
Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; CD3 Complex; Contrast Media; Cytokines; Female; Gadolinium; Leukocyte Elastase; Mice; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency; Skin; Transforming Growth Factor beta | 2021 |
Cellular and Molecular Pathways Underlying the Nephrotoxicity of Gadolinium.
Topics: Apoptosis; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Renal Insufficiency | 2022 |
Nephrogenic Systemic Fibrosis in the Setting of Transient Renal Insufficiency.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency | 2021 |
Detection of Kidney Dysfunction through
Topics: Animals; Contrast Media; Gadolinium; Kidney; Magnetic Resonance Imaging; Mice; Nanoparticles; Renal Insufficiency | 2022 |
Use of Gadolinium-Based Contrast Agents in Patients with Severe Renal Impairment. Absence of Risk Versus Caution: A Nephrologist's Perspective.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrologists; Renal Insufficiency | 2020 |
Gadolinium retention in a rat model of subtotal renal failure: are there differences among macrocyclic GBCAs?
Topics: Animals; Contrast Media; Creatinine; Gadolinium; Male; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Urea | 2023 |
A nephrotoxicity-free, iron-based contrast agent for magnetic resonance imaging of tumors.
Topics: Animals; Contrast Media; Gadolinium; Humans; Iron; Magnetic Resonance Imaging; Mice; Neoplasms; Renal Insufficiency | 2020 |
Gadolinium distribution in kidney tissue determined and quantified by micro synchrotron X-ray fluorescence.
Topics: Female; Fluorescence; Gadolinium; Humans; Middle Aged; Renal Insufficiency; Spectrometry, X-Ray Emission; Synchrotrons | 2021 |
Overlapping roles of NADPH oxidase 4 for diabetic and gadolinium-based contrast agent-induced systemic fibrosis.
Topics: Animals; Contrast Media; Diabetes Mellitus, Experimental; Fibrosis; Gadolinium; Kidney; Kidney Diseases; Mice; NADPH Oxidase 4; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency | 2021 |
Safety and Gadolinium Distribution of the New High-Relaxivity Gadolinium Chelate Gadopiclenol in a Rat Model of Severe Renal Failure.
Topics: Adenine; Animals; Azabicyclo Compounds; Brain; Contrast Media; Gadolinium; Gadolinium DTPA; Organometallic Compounds; Rats; Renal Insufficiency | 2021 |
4D flow image quality with blood pool contrast: a comparison of gadofosveset trisodium and ferumoxytol.
Topics: Adult; Aged; Aged, 80 and over; Coronary Circulation; Female; Ferrosoferric Oxide; Gadolinium; Heart Diseases; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Predictive Value of Tests; Prospective Studies; Renal Insufficiency; Reproducibility of Results; Risk Factors; Stroke Volume; Ventricular Function, Left; Ventricular Function, Right | 2018 |
Is it safe to use gadolinium-based contrast agents in MRI?
Topics: Blood-Brain Barrier; Brain; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency; Risk Factors | 2017 |
[Non-iodinated contrast media nephrotoxicity].
Topics: Contrast Media; Gadolinium; Humans; Kidney; Practice Guidelines as Topic; Radiography, Interventional; Renal Insufficiency; Risk Assessment; Risk Factors | 2018 |
Gadolinium tissue deposition in the periodontal ligament of mice with reduced renal function exposed to Gd-based contrast agents.
Topics: Animals; Contrast Media; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Mice; Nephrogenic Fibrosing Dermopathy; Periodontal Ligament; Renal Insufficiency; Tissue Distribution | 2019 |
Toxicological Risk Assessments of Iron Oxide Nanocluster- and Gadolinium-Based T1MRI Contrast Agents in Renal Failure Rats.
Topics: Animals; Contrast Media; Ferric Compounds; Gadolinium; HEK293 Cells; Humans; Magnetic Resonance Imaging; Mice; Nanostructures; Nephrogenic Fibrosing Dermopathy; Rats; Rats, Sprague-Dawley; RAW 264.7 Cells; Renal Insufficiency; Tissue Distribution | 2019 |
Tissue gadolinium deposition in renally impaired rats exposed to different gadolinium-based MRI contrast agents: evaluation with inductively coupled plasma mass spectrometry (ICP-MS).
Topics: Animals; Contrast Media; Gadolinium; Magnetic Resonance Imaging; Male; Metabolic Clearance Rate; Nephrogenic Fibrosing Dermopathy; Organ Specificity; Rats; Rats, Wistar; Renal Insufficiency; Risk Assessment; Spectrometry, Mass, Electrospray Ionization; Tissue Distribution | 2013 |
Time-dependent decrement of dermal gadolinium deposits and significant improvement of skin symptoms in a patient with nephrogenic systemic fibrosis after temporary renal failure.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Microscopy, Electron; Middle Aged; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency; Skin; Time | 2013 |
Type of MRI contrast, tissue gadolinium, and fibrosis.
Topics: Animals; Cells, Cultured; Contrast Media; Female; Fibroblasts; Fibronectins; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Rats, Inbred F344; Renal Insufficiency; Thermodynamics | 2014 |
Patient safety in vascular access patients on hemodialysis: contrast agents and renal function.
Topics: Contrast Media; Creatinine; Gadolinium; Glomerular Filtration Rate; Humans; Iodine; Kidney; Magnetic Resonance Imaging; Patient Safety; Radiography; Renal Dialysis; Renal Insufficiency; Renal Insufficiency, Chronic; Vascular Access Devices | 2015 |
Distribution profile of gadolinium in gadolinium chelate-treated renally-impaired rats: role of pharmaceutical formulation.
Topics: Animals; Chelating Agents; Chemistry, Pharmaceutical; Contrast Media; Femur; Gadolinium; Heterocyclic Compounds; Kidney; Liver; Male; Myocardium; Organometallic Compounds; Rats, Wistar; Renal Insufficiency; Skin | 2015 |
Renal safety of intravenous gadolinium-enhanced magnetic resonance imaging in patients awaiting liver transplantation.
Topics: Contrast Media; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Gadolinium; Humans; Infusions, Intravenous; Liver Cirrhosis; Liver Transplantation; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Renal Insufficiency; Reproducibility of Results; Retrospective Studies; Watchful Waiting | 2015 |
Nephrogenic systemic fibrosis: fibrotic plaques and contracture following exposure to gadolinium-based contrast media.
Topics: Contracture; Contrast Media; Elbow Joint; Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency; Skin | 2016 |
Impact of Impaired Renal Function on Gadolinium Retention After Administration of Gadolinium-Based Contrast Agents in a Mouse Model.
Topics: Animals; Contrast Media; Disease Models, Animal; Female; Gadolinium; Kidney; Mass Spectrometry; Mice; Renal Insufficiency | 2016 |
Four-dimensional phase-contrast vastly undersampled isotropic projection reconstruction (4D PC-VIPR) MR evaluation of the renal arteries in transplant recipients: Preliminary results.
Topics: Adult; Aged; Blood Flow Velocity; Contrast Media; Female; Gadolinium; Hemodynamics; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Kidney; Kidney Transplantation; Magnetic Resonance Angiography; Male; Middle Aged; Prospective Studies; Renal Artery; Renal Insufficiency; Reproducibility of Results; Time Factors; Tomography, X-Ray Computed; Transplant Recipients; Ultrasonography, Doppler | 2017 |
Enhanced biosafety of silica coated gadolinium based nanoparticles.
Topics: Biomedical Engineering; Cell Proliferation; Cell Survival; Contrast Media; Fibroblasts; Gadolinium; Humans; Hydrogen-Ion Concentration; L-Lactate Dehydrogenase; Magnetic Resonance Imaging; Magnetite Nanoparticles; Metal Nanoparticles; Microscopy, Electron, Transmission; Nanotechnology; Necrosis; Pancreatitis; Propylamines; Renal Insufficiency; Silanes; Silicon Dioxide; Spectroscopy, Fourier Transform Infrared; Temperature; X-Ray Diffraction | 2017 |
Periocular papules in nephrogenic systemic fibrosis.
Topics: Adult; Contrast Media; Face; Facial Dermatoses; Female; Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Middle Aged; Renal Insufficiency | 2008 |
Risk of nephrogenic systemic fibrosis: evaluation of gadolinium chelate contrast agents at four American universities.
Topics: Academic Medical Centers; Adolescent; Adult; Aged; Chelating Agents; Comorbidity; Gadolinium; Humans; Incidence; Magnetic Resonance Imaging; Middle Aged; Renal Insufficiency; Risk Assessment; Risk Factors; Scleroderma, Systemic; Syndrome; United States | 2008 |
Incidence of nephrogenic systemic fibrosis at two large medical centers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chelating Agents; Comorbidity; Gadolinium; Humans; Incidence; Magnetic Resonance Imaging; Middle Aged; New York; Renal Insufficiency; Retrospective Studies; Risk Assessment; Risk Factors; Scleroderma, Systemic; Syndrome | 2008 |
[Risk of using gadolinium in patients with renal insufficiency].
Topics: Gadolinium; Humans; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency | 2008 |
Nephrogenic systemic fibrosis and gadolinium: a perfect storm.
Topics: Contrast Media; Drug Approval; Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Renal Insufficiency; Skin Diseases; United States; United States Food and Drug Administration | 2008 |
Gadolinium-based contrast agents and nephrogenic systemic fibrosis.
Topics: Academic Medical Centers; Adolescent; Adult; Aged; Chelating Agents; Comorbidity; Gadolinium; Humans; Incidence; Magnetic Resonance Imaging; Middle Aged; Renal Insufficiency; Risk Assessment; Risk Factors; Scleroderma, Systemic; Syndrome; United States | 2009 |
Impact of renal impairment on long-term retention of gadolinium in the rodent skin following the administration of gadolinium-based contrast agents.
Topics: Animals; Contrast Media; Gadolinium; Male; Nephrogenic Fibrosing Dermopathy; Rats; Rats, Wistar; Renal Insufficiency; Skin | 2009 |
[Nephrogenic systemic fibrosis].
Topics: Collagen; Gadolinium; Humans; Liver Transplantation; Nephrogenic Fibrosing Dermopathy; Pressure; Renal Insufficiency; Risk Factors | 2009 |
Is nephrogenic systemic fibrosis linked to the introduction of contrast-enhanced MR angiography?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chelating Agents; Comorbidity; Gadolinium; Humans; Incidence; Magnetic Resonance Imaging; Middle Aged; New York; Renal Insufficiency; Retrospective Studies; Risk Assessment; Risk Factors; Scleroderma, Systemic; Syndrome | 2009 |
Renal failure and gadolinium. The number of documented cases is rising.
Topics: Contrast Media; France; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency | 2008 |
Nephrogenic systemic fibrosis: an unusual scleroderma-like fibrosing disorder.
Topics: Aged; Diagnosis, Differential; Eosinophilia; Fasciitis; Fatal Outcome; Female; Gadolinium; Humans; Myxedema; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency; Scleroderma, Systemic; Skin | 2010 |
Gadolinium-associated nephrogenic systemic fibrosis.
Topics: Contraindications; Contrast Media; Gadolinium; Glomerular Filtration Rate; Humans; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency; Risk Factors | 2009 |
Guideline to use gadolinium-based contrast agents at Kyoto University Hospital.
Topics: Contrast Media; Dose-Response Relationship, Drug; Gadolinium; Hospitals; Humans; Japan; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Practice Guidelines as Topic; Renal Insufficiency | 2009 |
Gadolinium-associated nephrogenic systemic fibrosis in patients with renal failure: the need for an interdisciplinary helping network.
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency | 2010 |
The biodistribution of [153Gd]Gd-labeled magnetic resonance contrast agents in a transgenic mouse model of renal failure differs greatly from control mice.
Topics: Animals; Contrast Media; Disease Models, Animal; Gadolinium; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nephritis, Hereditary; Organ Specificity; Renal Insufficiency; Species Specificity; Tissue Distribution | 2010 |
Ocular pathologic features and gadolinium deposition in nephrogenic systemic fibrosis.
Topics: Conjunctival Diseases; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Microscopy, Electron, Scanning; Middle Aged; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency; Scleral Diseases; Spectrometry, X-Ray Emission; Young Adult | 2011 |
Nephrogenic systemic fibrosis is found only among gadolinium-exposed patients with renal insufficiency: a case-control study from Denmark.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Case-Control Studies; Child; Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organophosphates; Renal Dialysis; Renal Insufficiency; Risk Factors; Young Adult | 2011 |
Hyperphosphataemia sensitizes renally impaired rats to the profibrotic effects of gadodiamide.
Topics: Animals; Contrast Media; Disease Models, Animal; Femur; Gadolinium; Gadolinium DTPA; Hyperphosphatemia; Liver; Male; Nephrogenic Fibrosing Dermopathy; Procollagen-Proline Dioxygenase; Rats; Rats, Wistar; Renal Insufficiency; Risk Factors; Skin; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta1 | 2012 |
Stimulation of fibroblast proliferation by insoluble gadolinium salts.
Topics: Calcium; Cell Proliferation; Cells, Cultured; Contrast Media; Dermis; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Phosphatidylinositol 3-Kinases; Renal Insufficiency; Salts; Solubility | 2012 |
Incidence of nephrogenic systemic fibrosis at a large university hospital in Sweden.
Topics: Aged; Aged, 80 and over; Contrast Media; Female; Gadolinium; Glomerular Filtration Rate; Hospitals, University; Humans; Incidence; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Renal Dialysis; Renal Insufficiency; Retrospective Studies; Sweden | 2012 |
Distribution of estimated glomerular filtration rate (eGFR) values in patients receiving contrast-enhanced magnetic resonance imaging.
Topics: Aged; Contrast Media; Female; Gadolinium; Glomerular Filtration Rate; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency | 2012 |
Editorial comment from Dr Ishii to recent topics related to nephrogenic systemic fibrosis associated with gadolinium-based contrast agents.
Topics: Contrast Media; Gadolinium; Humans; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency | 2012 |
Editorial comment from Dr Mori to recent topics related to nephrogenic systemic fibrosis associated with gadolinium-based contrast agents.
Topics: Contrast Media; Gadolinium; Humans; Nephrogenic Fibrosing Dermopathy; Renal Insufficiency | 2012 |
Nephrogenic systemic fibrosis-like effects of magnetic resonance imaging contrast agents in rats with adenine-induced renal failure.
Topics: Adenine; Animals; Bone and Bones; Contrast Media; Diet; Disease Models, Animal; Gadolinium; Kidney; Kidney Function Tests; Male; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Rats; Rats, Wistar; Renal Insufficiency; Skin; Spectrophotometry, Atomic; Tissue Distribution | 2013 |
[Gadolinium in arteriography and interventional radiology: 39 patients].
Topics: Aged; Aged, 80 and over; Angiography, Digital Subtraction; Angioplasty; Contraindications; Contrast Media; Creatinine; Embolization, Therapeutic; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Iodine Isotopes; Male; Middle Aged; Organometallic Compounds; Patient Selection; Radiology, Interventional; Renal Insufficiency; Treatment Outcome; Vascular Diseases | 2002 |
[Microcatheterization with gadolinium and glue embolization for post-biopsy arteriovenous fistula in a patient with renal failure].
Topics: Adhesives; Adolescent; Arteriovenous Fistula; Biopsy; Catheterization; Embolization, Therapeutic; Gadolinium; Humans; Male; Radiography; Renal Insufficiency | 2002 |
[Experience of cerebral angiography using gadolinium for renal insufficiency].
Topics: Aged; Angiography, Digital Subtraction; Angioplasty, Balloon; Cerebral Angiography; Contrast Media; Female; Gadolinium; Humans; Renal Insufficiency; Vertebrobasilar Insufficiency | 2003 |
Gadolinium-enhanced coronary angiography in patients with impaired renal function.
Topics: Aged; Aged, 80 and over; Contrast Media; Coronary Angiography; Female; Gadolinium; Humans; Male; Middle Aged; Prospective Studies; Renal Insufficiency | 2003 |
Gadodiamide administration causes spurious hypocalcemia.
Topics: Calcium; Contrast Media; Creatinine; Female; Gadolinium; Gadolinium DTPA; Humans; Hypocalcemia; Injections, Intravenous; Magnetic Resonance Angiography; Male; Middle Aged; Prevalence; Renal Insufficiency; Retrospective Studies | 2003 |
Gadolinium-based contrast media may be nephrotoxic even at approved doses.
Topics: Aged; Contrast Media; Diabetic Nephropathies; Diagnosis, Differential; Dose-Response Relationship, Drug; Gadolinium; Gadolinium DTPA; Humans; Kidney Function Tests; Magnetic Resonance Angiography; Male; Renal Artery Obstruction; Renal Insufficiency | 2004 |
Gadolinium encephalopathy in a patient with renal failure.
Topics: Amnesia, Retrograde; Brain; Brain Diseases, Metabolic; Causality; Cerebrospinal Fluid; Consciousness Disorders; Female; Gadolinium; Humans; Hypertension; Magnetic Resonance Imaging; Metabolic Clearance Rate; Middle Aged; Patient Selection; Recovery of Function; Renal Insufficiency | 2005 |
Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis.
Topics: Acidosis; Contrast Media; Electron Probe Microanalysis; Fibrosis; Gadolinium; Humans; Iron; Lysosomes; Metals; Microscopy, Electron, Scanning; Organ Specificity; Paraffin Embedding; Pilot Projects; Renal Insufficiency; Single-Blind Method; Skin; Skin Diseases | 2007 |
Erythropoietin, gadolinium, and nephrogenic fibrosing dermopathy.
Topics: Erythropoietin; Fibrosis; Gadolinium; Humans; Recombinant Proteins; Renal Insufficiency; Skin Diseases | 2007 |
Nephrogenic systemic fibrosis: a clinicopathologic study of six cases.
Topics: Adult; Aged; Contrast Media; Erythropoietin; Female; Fibrosis; Gadolinium; Humans; Male; Middle Aged; Renal Dialysis; Renal Insufficiency; Retrospective Studies; Skin Diseases; Surgical Procedures, Operative | 2007 |
[Acute renal failure after gadolinium-containing contrast medium in preexisting chronic renal failure stage II].
Topics: Acute Kidney Injury; Aged; Cholangiopancreatography, Magnetic Resonance; Contrast Media; Female; Gadolinium; Gallstones; Heterocyclic Compounds; Humans; Immunoglobulin kappa-Chains; Kidney Function Tests; Monoclonal Gammopathy of Undetermined Significance; Organometallic Compounds; Renal Insufficiency | 2007 |
Nephrogenic systemic fibrosis--the beginning of the end?
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Renal Dialysis; Renal Insufficiency; Skin Diseases | 2007 |
Nephrogenic systemic fibrosis, kidney disease, and gadolinium: is there a link?
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Renal Insufficiency | 2007 |
Nephrogenic systemic fibrosis, gadolinium, and iron mobilization.
Topics: Contrast Media; Fatal Outcome; Fibrosis; Gadolinium; Humans; Iron; Renal Insufficiency; Skin Diseases | 2007 |
Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort.
Topics: Adult; Aged; Contrast Media; Female; Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Renal Dialysis; Renal Insufficiency; Retrospective Studies; Skin Diseases | 2007 |
Response to the FDA's May 23, 2007, nephrogenic systemic fibrosis update.
Topics: Contrast Media; Fibrosis; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Renal Insufficiency; Risk; United States; United States Food and Drug Administration | 2008 |
Nephrogenic systemic fibrosis after exposure to gadolinium in patients with renal failure.
Topics: Adult; Contrast Media; Fibrosis; Gadolinium; Humans; Kidney Failure, Chronic; Magnetic Resonance Imaging; Peritoneal Dialysis, Continuous Ambulatory; Renal Insufficiency; Retrospective Studies; Skin Diseases | 2007 |
Transglutaminases: the missing link in nephrogenic systemic fibrosis.
Topics: Antigens, CD; Antigens, Differentiation, Myelomonocytic; Biopsy; Case-Control Studies; Contrast Media; Factor XIIIa; Female; Fibroblasts; Fibrosis; Gadolinium; Histiocytes; Humans; Male; Middle Aged; Renal Insufficiency; Skin; Skin Diseases; Syndrome; Transglutaminases | 2007 |
[The Grenelle of MR contrast agents?].
Topics: Contrast Media; Europe; Fibrosis; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Product Surveillance, Postmarketing; Renal Insufficiency; United States; United States Food and Drug Administration | 2007 |
Introduction to this issue on NSF.
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Renal Insufficiency; Skin; Skin Diseases | 2008 |
Impact on hospital policy: Yale experience.
Topics: Connecticut; Contrast Media; Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Organizational Case Studies; Radiology Department, Hospital; Renal Insufficiency; Safety Management; Skin; Skin Diseases | 2008 |
Gadolinium-induced nephrogenic systemic fibrosis in patients with kidney and liver disease.
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Liver Failure; Magnetic Resonance Imaging; Renal Insufficiency; Risk Factors; Skin Diseases | 2008 |
Comparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic renal artery stenosis: clinical outcomes.
Topics: Aged; Angiography, Digital Subtraction; Angioplasty, Balloon; Atherosclerosis; Contrast Media; Creatinine; Female; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Incidence; Injections, Intravenous; Iohexol; Male; Minnesota; Organometallic Compounds; Renal Artery Obstruction; Renal Insufficiency; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Triiodobenzoic Acids | 2008 |
[Nephrogenic systemic fibrosis possibly caused by gadolinium-containing contrast agent].
Topics: Adult; Contrast Media; Female; Fibrosis; Gadolinium; Humans; Renal Insufficiency; Skin Diseases | 2007 |
Nephrogenic systemic fibrosis: a report of 29 cases.
Topics: Adult; Aged; Cohort Studies; Contrast Media; Databases, Factual; Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Middle Aged; Prevalence; Renal Dialysis; Renal Insufficiency; Retrospective Studies; Skin Diseases | 2008 |
Gadolinium exposure in organ donors may cause nephrogenic system fibrosis in transplant recipients never exposed to gadolinium.
Topics: Fibrosis; Gadolinium; Glomerular Filtration Rate; Heart Transplantation; Humans; Kidney Transplantation; Postoperative Complications; Renal Insufficiency; Tissue Donors | 2008 |
Possibly enhanced Gd excretion in dialysate, but no major clinical benefit of 3-5 months of treatment with sodium thiosulfate in late stages of nephrogenic systemic fibrosis.
Topics: Adult; Chelating Agents; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Hemodialysis Solutions; Humans; Magnetic Resonance Imaging; Middle Aged; Nephrogenic Fibrosing Dermopathy; Renal Dialysis; Renal Insufficiency; Thiosulfates; Time Factors | 2008 |
Nephrogenic systemic fibrosis: a chemical perspective.
Topics: Contrast Media; Fibrosis; Gadolinium; Humans; Magnetic Resonance Imaging; Molecular Structure; Renal Insufficiency; Skin Diseases; Thermodynamics | 2008 |
Nephrogenic systemic fibrosis in Japan: advisability of keeping the administered dose as low as possible.
Topics: Contrast Media; Fibrosis; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Renal Insufficiency; Risk; Risk Factors | 2008 |
Systemic gadolinium toxicity in patients with renal insufficiency and renal failure: retrospective analysis of an initial experience.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Contrast Media; Creatinine; Female; Gadolinium; Humans; Incidence; Magnetic Resonance Imaging; Male; Middle Aged; Renal Insufficiency; Retrospective Studies; Survival Analysis | 1996 |
[Nephrotoxicity of contrast media in magnetic resonance tomography (MRI)].
Topics: Animals; Contrast Media; Dose-Response Relationship, Drug; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Kidney Function Tests; Magnetic Resonance Imaging; Organometallic Compounds; Renal Insufficiency | 1997 |
Gadolinium-based contrast agents as an alternative at vena cavography in patients with renal insufficiency--early experience.
Topics: Adult; Aged; Aged, 80 and over; Angiography, Digital Subtraction; Carbon Dioxide; Contrast Media; Creatinine; Female; Gadolinium; Humans; Male; Middle Aged; Renal Insufficiency; Vena Cava Filters; Vena Cava, Inferior | 1999 |
Use of gadolinium as an intraarterial contrast agent in digital subtraction angiography of the cervical carotid arteries and intracranial circulation. Technical note.
Topics: Angiography, Digital Subtraction; Arteriosclerosis; Basilar Artery; Carotid Arteries; Carotid Artery Diseases; Carotid Artery, Common; Carotid Artery, Internal; Carotid Stenosis; Catheterization, Peripheral; Cerebrovascular Circulation; Contraindications; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Injections, Intra-Arterial; Iodine; Ischemic Attack, Transient; Neck; Renal Insufficiency; Vertebral Artery | 2000 |
[Endovascular stent graft support exclusion of an infrarenal aortic aneurysm using gadolinium as contrast medium in kidney insufficiency].
Topics: Aortic Aneurysm, Abdominal; Contrast Media; Gadolinium; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Renal Insufficiency; Stents; Tomography, X-Ray Computed | 2001 |